TOPLINE
In this interview with “Dr. Jane Ruby” Canadian ER physician Dr. Daniel Nagase describes the reasons he believes it’s possible the mRNA from Pfizer and Moderna’s COVID-19 “vaccines” may integrate into the human genome. Specifically, Nagase notes that the mRNA sequences from the injections have particularly long “poly(A) tails,” which may allow the naturally occurring gene LINE-1 to carry them into the nucleus of the cell.
Note: Nagase’s discussion of the COVID injections and how their mRNA may integrate into the human genome begins around the 24:30 mark in the video.
In a new interview with “Dr. Jane Ruby” ER physician Dr. Daniel Nagase discusses how he had his medical license revoked in early 2021, as well as the myriad reasons he believes there is a possibility that the mRNA from Pfizer and Moderna’s COVID-19 “vaccines” may reverse transcribe into a cell’s nucleus, and, ultimately, its genome. Nagase, who has previously brought forth mind-blowing evidence of strange “chip structures” in the COVID injections, focuses largely on the “poly(A) tail” present on the mRNA sequences in both Pfizer’s and Moderna’s injections.
Toward the middle of the video, Nagase describes the importance of the COVID injection mRNA containing poly(A) tails, noting that they allow LINE-1, a naturally occurring gene, to potentially carry the DNA for the spike protein the injections’ mRNA codes for into the nucleus of the cell, and, potentially, the genome.
As Nagase describes, LINE-1 (mysteriously) goes back and forth between the inside of a cell’s nucleus and its cytoplasm. The gene not only goes back and forth, into and out of a cell’s nucleus, but it is also able to carry proteins into the nucleus thanks to its poly(A) tail—that is, a long “tail” of adenine nucleotides at the end of its genetic sequence. LINE-1, Nagase notes, has 37 adenine nucleotides in a row that make up its “tail.”
Once LINE-1 leaves the nucleus as mRNA—with an mRNA version of its poly(A) tail—it transcribes two proteins (ORF1 and ORF2), which subsequently attach to the LINE-1 mRNA. LINE-1 then carries those proteins back into the nucleus thanks to their pairing with its poly(A) tail. Critically, Nagase notes that ORF1 and ORF2 are “transport proteins” that can carry mRNA from the cytoplasm into the nucleus, where the proteins are able to insert the carried mRNA into the DNA that’s inside the nucleus.
In regard to Pfizer and Moderna’s COVID injections—which Nagase has previously said need to be removed from the market (hear more about that via the post embedded immediately below)—the ER physician notes their poly(A) tails, which are 70 adenines long and 100 adenines long respectively, are far longer than LINE-1’s 37-adenine-long tail. Which means, according to Nagase, that “they can attach to the nuclear transport proteins made by LINE-1 the same way LINE-1 attaches to its own proteins for transport into and out of the nucleus.”
“[I]f something has a poly(A) tail, that increases the chances of a reverse transcriptase, such as LINE-1, taking it into the nucleus and inserting into the DNA,” Nagase says, bringing the explanation together.
As for whether or not the mRNA from Pfizer and Moderna’s COVID injections actually does hitch a ride on LINE-1 back into the nucleus by binding with its transport proteins, it seems the jury is still out. Nagase does note, however, a study performed by Rudolf Jaenisch et al., which looked at a segment of mRNA (a plasmid), that had a poly(A) tail that was only 25 adenines long “and he found that it didn’t, for the most part, get inserted into the DNA.”
Nagase notes, however, that the poly(A) tail of LINE-1 is 33 adenines long; long enough to carry ORF1 and ORF2 into the nucleus, and obviously much shorter than Pfizer’s 70-adenine-long tail or Moderna’s 100-adenine-long tail. “So my question,” Nagase says, “is were they [Pfizer and Moderna] trying to increase the chances of the spike protein mRNA… [being transported] into the nucleus by making a ridiculously long poly-A tail.”
Unfortunately, Nagase notes that Jaenisch, “a smart cell biologist,” didn’t bother to test poly(A) tails that are 33, 100, or 70 adenines long, even though he could have obtained samples of both Moderna’s and Pfizer’s COVID injections. (The 33-adenine-long tail would’ve been to test LINE-1’s tail, presumably as a control.) “Why did he avoid doing that one test?” Nagase asks rhetorically.
As for the stated reason why Moderna and Pfizer put such long poly(A) tails on their mRNA, Nagase says the pharma companies said it was “to prevent the mRNA from getting degraded in the cell too quickly.” But he responds to that by puzzling over the fact that they decided to go for tails 2-3 times longer than a natural tail. “How long did they intend for the mRNA to last in the cell?” Nagase asks rhetorically. He wonders aloud if they aimed for “forever mRNA… that never gets degraded.”
Aside from what Ruby and Nagase discuss in this interview, also note that a peer-reviewed study published in Current Issues in Molecular Biology in February of 2022 found that “BNT162b2 mRNA is reverse transcribed intracellularly into DNA in as fast as 6 [hours] upon BNT162b2 exposure.” BNT162b2 is one name for Pfizer’s injection.
As for the mechanism of action, the authors of the Current Issues paper wrote that it’s possible reverse transcription was indeed happening via LINE-1. Read more about that study via the post embedded immediately above.
Feature image: National Human Genome Research Institution
Related News
